Profusa (PFSA) Shares Outstanding (2021 - 2026)
Profusa's (PFSA) quarterly Shares Outstanding (Entity) came in at $57676.0 in Q2 2026, up 11.05% on a YoY basis from $51938.0 in Q2 2025, and up 28.26% quarter-over-quarter from $44967.0 in Q1 2026.
Analysis
Profusa (PFSA) Shares Outstanding (2021 - 2026) Analysis & Trends
Profusa (PFSA) has reported Shares Outstanding (Entity) for 6 consecutive years, with $57676.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 11.05% year-over-year to $57676.0; the trailing twelve-month figure through Jun 2026 stood at $57676.0 (up 11.05% YoY), and the FY2025 full-year result was $3348.0, down 93.55% from the prior year.
- Shares Outstanding (Entity) rose to $57676.0 in Q2 2026 per PFSA's latest filing, from $44967.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $317311.0 in Q3 2025 and bottomed at $3348.0 in Q4 2025.
- Historically, Shares Outstanding (Entity) has averaged $79557.6 across 5 years, with a median of $54807.0 in 2022.
- The widest YoY moves for Shares Outstanding (Entity): up 510.94% in 2025, down 93.55% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $92167.0 in 2022, then changed by 0.0% to $92167.0 in 2023, then slumped by 43.65% to $51938.0 in 2024, then tumbled by 93.55% to $3348.0 in 2025, then jumped by 1622.7% to $57676.0 in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $57676.0, $44967.0, and $3348.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Profusa | 141,306.20 | -577,693.80 | - | 57,676.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57,676.00 |
| Mar 31, 2026 | 16,881.00 |
| Dec 31, 2025 | 3,348.00 |
| Sep 30, 2025 | 317,311.00 |
| Jun 30, 2025 | 51,938.00 |
| Mar 31, 2025 | 51,938.00 |
| Dec 31, 2024 | 51,938.00 |
| Sep 30, 2024 | 51,938.00 |
| Jun 30, 2024 | 51,938.00 |
| Mar 31, 2024 | 51,938.00 |
| Dec 31, 2023 | 51,938.00 |
| Sep 30, 2023 | 51,938.00 |
| Jun 30, 2023 | 51,938.00 |
| Mar 31, 2023 | 51,938.00 |
| Dec 31, 2022 | 51,938.00 |
| Sep 30, 2022 | 51,938.00 |
| Jun 30, 2022 | 51,938.00 |
| Mar 31, 2022 | 51,938.00 |
| Dec 31, 2021 | 41,666.00 |